Dr. Mehta on Stem Cell Transplant in Multiple Myeloma

Jayesh Mehta, MD
Published: Friday, Nov 10, 2017



Jayesh Mehta, MD, professor of medicine (hematology and oncology), Feinberg School of Medicine, discusses stem cell transplant in multiple myeloma.

Many people do not like stem cell transplantation, but studies show that eliminating it from treatment only hurts the patient, says Mehta.

With curable diseases with different pathways, it is acceptable to choose 1 form of treatment over another, but that is not the case for incurable diseases, explains Mehta.


Jayesh Mehta, MD, professor of medicine (hematology and oncology), Feinberg School of Medicine, discusses stem cell transplant in multiple myeloma.

Many people do not like stem cell transplantation, but studies show that eliminating it from treatment only hurts the patient, says Mehta.

With curable diseases with different pathways, it is acceptable to choose 1 form of treatment over another, but that is not the case for incurable diseases, explains Mehta.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x